Pneumonia Global Clinical Trials Review, H2, 2016 - Trial Status, Trial Phase, Sponsor Type & End point Status - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pneumonia Global Clinical Trials Review, H2, 2016" clinical trials to their offering.

The clinical trial report provides an overview of Pneumonia clinical trials scenario. This report provides top line data relating to the clinical trials on Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope of the Report:

  • The report provides a snapshot of the global clinical trials landscape.
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
  • The Report provides enrollment trends for the past five years.
  • Report provides latest news for the past three months.

Companies Mentioned

  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • AstraZeneca Plc
  • Sanofi
  • Allergan Plc
  • Bayer AG
  • Johnson & Johnson
  • TaiGen Biopharmaceuticals Holdings Ltd
  • Fujifil

For more information about this clinical trials report visit http://www.researchandmarkets.com/research/wgjvlr/pneumonia_global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials